Furthermore, we found that the 2b-AGO interaction redistributed the localization of both the 2b and AGO proteins in the nucleus, inhibited AGO1 slicer activity in vivo, and suppressed RDR-dependent antiviral silencing in the context of CMV infection [29,30,32]. The gene discussed is SLC1A5; the disease is cytomegalovirus infection.